期刊文献+

良性前列腺增生治疗药物对前列腺细胞增殖与凋亡的影响

Effect of therapeutic drugs for benign prostatic hyperplasia on proliferation and apoptosis of prostatic cells
下载PDF
导出
摘要 前列腺细胞的增殖和凋亡受多种因素调节 ,细胞增殖率上调和细胞凋亡率下调是良性前列腺增生的重要原因。此文简要介绍良性前列腺增生治疗药物的一般作用机制 。
出处 《中国生化药物杂志》 CAS CSCD 2004年第3期184-186,共3页 Chinese Journal of Biochemical Pharmaceutics
  • 相关文献

参考文献18

  • 1David LH, Adam TG, Patricia F, et al. Epithelial Cell Differentiation Pathways in the Human Prostate: Identification of Intermediate Phenotypes by Keratin Expression[J]. J Histochem Cytochem, 2001,49(2): 271-278.
  • 2Kyprianou N, Jacobs SC. Induction of apoptosis in the prostate by alphal-adrenoceptor antagonists: a novel effect of "old" drugs [J]. Curr Urol Rep, 2000, 1(2):89-96.
  • 3Boesch ST, Dobler G, Ramoner R, et al. Effects of α1-adrenoceptor antagonists on culture prostatic smooth muscle cells[J]. Prostate,2000,45(4):34-39.
  • 4Kirby RS, Roehrborn C, Boyle P, et al. Efficacy and tolerability of doxazosin and finastefide, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the prospective european doxazosin and combination therapy (PREDICT) trial[J]. Urol, 2003,61(1):119-126.
  • 5Cuellar DC, Rhee J, Kyprianou N. Alphal-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction[J]. Anticancer Res,2002,22(3):1673-1679.
  • 6Murakoshi M, Ikeda R, Fukui N, et al. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadianne acetate (CMA) [J]. Tokai J Exp Clin Med, 2001,26(2):71-75.
  • 7Falkman J. Is tissue mass regulated by vascular endothelial cell: prostate as the first evidence[J]. Endocrinol, 1998,139(11):441-444.
  • 8Coffey DS. Controversies in the management of lower urinary tract symptoms: an overview[J]. Brit J Urol, 1998,81(Suppl 1):1-5.
  • 9Wu SF, Sun HZ, Qi XD, et al. Effect of epristeride on the expression of IGF-1and TGF-β receptors in androgen-induced castrated rat prostate[J].Exp Biol Med, 2001,226(10):954-960.
  • 10Roehrborn CG, Boyle P, Nickel JC, et al. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2(dutasteride) in men with benign prostatic hyperplasia [J]. Urol, 2002,60(3) :434-441.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部